{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:33:20Z","timestamp":1774571600800,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-024-10475-x","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T11:59:06Z","timestamp":1734091146000},"page":"443-451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peripartum cardiomyopathy in the twenty-first century: a review of the pathophysiology and clinical trials for novel disease-specific therapeutics"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-9775","authenticated-orcid":false,"given":"Kristen","family":"Callender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2438-3056","authenticated-orcid":false,"given":"Lee-Ann","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"issue":"181","key":"10475_CR1","first-page":"325","volume":"72","author":"C Ritchie","year":"1849","unstructured":"Ritchie C (1849) Clinical contributions to the pathology, diagnosis, and treatment of certain chronic diseases of the heart. Edinburgh Med Surg J 72(181):325","journal-title":"Edinburgh Med Surg J"},{"issue":"4","key":"10475_CR2","doi-asserted-by":"publisher","first-page":"596","DOI":"10.7326\/0003-4819-27-4-596","volume":"27","author":"JP Melvin Jr","year":"1947","unstructured":"Melvin JP Jr (1947) Post-partal heart disease. Ann Intern Med 27(4):596\u2013609","journal-title":"Ann Intern Med"},{"issue":"5","key":"10475_CR3","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/01.CIR.44.5.964","volume":"44","author":"JG Demakis","year":"1971","unstructured":"Demakis JG, Rahimtoola SH (1971) Peripartum cardiomyopathy. Circulation 44(5):964\u2013968","journal-title":"Circulation"},{"issue":"8","key":"10475_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","volume":"12","author":"K Sliwa","year":"2010","unstructured":"Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12(8):767\u2013778","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"10475_CR5","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/01.CIR.0000162478.36652.7E","volume":"111","author":"U Elkayam","year":"2005","unstructured":"Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A (2005) Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111(16):2050\u20132055","journal-title":"Circulation"},{"issue":"2","key":"10475_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jacc.2019.11.014","volume":"75","author":"MB Davis","year":"2020","unstructured":"Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U (2020) Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 75(2):207\u2013221","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10475_CR7","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/ejhf.882","volume":"19","author":"AS Ersb\u00f8ll","year":"2017","unstructured":"Ersb\u00f8ll AS, Johansen M, Damm P, Rasmussen S, Vejlstrup NG, Gustafsson F (2017) Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome. Eur J Heart Fail 19(12):1712\u20131720","journal-title":"Eur J Heart Fail"},{"issue":"23","key":"10475_CR8","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1136\/heartjnl-2011-300349","volume":"97","author":"LA Blauwet","year":"2011","unstructured":"Blauwet LA, Cooper LT (2011) Diagnosis and management of peripartum cardiomyopathy. Heart 97(23):1970\u20131981","journal-title":"Heart"},{"issue":"2","key":"10475_CR9","first-page":"228","volume":"17","author":"SA Isezuo","year":"2007","unstructured":"Isezuo SA, Abubakar SA (2007) Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis 17(2):228\u2013233","journal-title":"Ethn Dis"},{"issue":"48","key":"10475_CR10","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.1093\/eurheartj\/ehad626","volume":"44","author":"AM Jackson","year":"2023","unstructured":"Jackson AM, Macartney M, Brooksbank K, Brown C, Dawson D, Francis M, Japp A, Lennie V, Leslie SJ, Martin T, Neary P (2023) A 20-year population study of peripartum cardiomyopathy. Eur Heart J 44(48):5128\u20135141","journal-title":"Eur Heart J"},{"issue":"3","key":"10475_CR11","doi-asserted-by":"publisher","first-page":"e001056","DOI":"10.1161\/JAHA.114.001056","volume":"3","author":"D Kolte","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, Jain D, Gass A, Ahmed A, Panza JA, Fonarow GC (2014) Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc 3(3):e001056","journal-title":"J Am Heart Assoc"},{"key":"10475_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cardfail.2013.03.004.geographicalvariations","volume":"19","author":"S Goland","year":"2013","unstructured":"Goland S, Modi K, Hatamizadeh P, Elkayam U (2013) Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. J Card Fail 19:214\u2013218. https:\/\/doi.org\/10.1016\/j.cardfail.2013.03.004.geographicalvariations","journal-title":"J Card Fail"},{"issue":"5","key":"10475_CR13","first-page":"409","volume":"1","author":"DP Kao","year":"2013","unstructured":"Kao DP, Hsich E, Lindenfeld J (2013) Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC: Heart Fail 1(5):409\u2013416","journal-title":"JACC: Heart Fail"},{"issue":"11","key":"10475_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/jamacardio.2017.3574","volume":"2","author":"OC Irizarry","year":"2017","unstructured":"Irizarry OC, Levine LD, Lewey J, Boyer T, Riis V, Elovitz MA, Arany Z (2017) Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non\u2013African American women. JAMA cardiology 2(11):1256\u20131260","journal-title":"JAMA cardiology"},{"issue":"8","key":"10475_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","volume":"66","author":"DM McNamara","year":"2015","unstructured":"McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, Modi K, Alexis JD, Ramani GV, Semigran MJ, Haythe J (2015) Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 66(8):905\u2013914","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10475_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1067\/mhj.2000.110091","volume":"140","author":"GM Felker","year":"2000","unstructured":"Felker GM, Jaeger CJ, Klodas E, Thiemann DR, Hare JM, Hruban RH, Kasper EK, Baughman KL (2000) Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 140(5):785\u2013791","journal-title":"Am Heart J"},{"issue":"5","key":"10475_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/0002-9149(94)90906-7","volume":"74","author":"MN Rizeq","year":"1994","unstructured":"Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME (1994) Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 74(5):474\u2013477","journal-title":"Am J Cardiol"},{"issue":"3","key":"10475_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1505517","volume":"374","author":"JS Ware","year":"2016","unstructured":"Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, Tsai EJ, Hilfiker-Kleiner D, Kamiya CA, Mazzarotto F, Cook SA (2016) Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med 374(3):233\u2013241","journal-title":"N Engl J Med"},{"issue":"32","key":"10475_CR19","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/eurheartj\/ehu050","volume":"35","author":"KY van Spaendonck-Zwarts","year":"2014","unstructured":"van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, Hilfiker-Kleiner D, Bollen IA, Sliwa K, Alders M, Almomani R, van Langen IM, van der Meer P, Sinke RJ (2014) Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J 35(32):2165\u20132173","journal-title":"Eur Heart J"},{"issue":"20","key":"10475_CR20","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.109.929646","volume":"121","author":"KY van Spaendonck-Zwarts","year":"2010","unstructured":"van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, Dooijes D, van den Berg MP (2010) Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 121(20):2169\u20132175","journal-title":"Circulation"},{"issue":"20","key":"10475_CR21","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.109.931220","volume":"121","author":"A Morales","year":"2010","unstructured":"Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, Hershberger RE (2010) Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 121(20):2176\u20132182","journal-title":"Circulation"},{"issue":"3","key":"10475_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","volume":"128","author":"D Hilfiker-Kleiner","year":"2007","unstructured":"Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M (2007) A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128(3):589\u2013600","journal-title":"Cell"},{"issue":"2","key":"10475_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cardfail.2021.01.002","volume":"27","author":"AS Ersb\u00f8ll","year":"2021","unstructured":"Ersb\u00f8ll AS, Goetze JP, Johansen M, Hauge MG, Sliwa K, Vejlstrup N, Gustafsson F, Damm P (2021) Biomarkers and their relation to cardiac function late after peripartum cardiomyopathy. J Cardiac Fail 27(2):168\u2013175","journal-title":"J Cardiac Fail"},{"issue":"5","key":"10475_CR24","first-page":"1151","volume":"152","author":"K Roberg","year":"1998","unstructured":"Roberg K, Ollinger K (1998) Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 152(5):1151","journal-title":"Am J Pathol"},{"issue":"5","key":"10475_CR25","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1172\/JCI64365","volume":"123","author":"J Halkein","year":"2013","unstructured":"Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Scherr M, Castermans K, Malvaux L, Lambert V, Thiry M, Sliwa K, Noel A (2013) MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Investig 123(5):2143\u20132154","journal-title":"J Clin Investig"},{"issue":"3","key":"10475_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/humrep\/14.3.827","volume":"14","author":"AE O'connor","year":"1999","unstructured":"O\u2019connor AE, McFarlane JR, Hayward S, Yohkaichiya T, Groome NP, de Kretser DM (1999) Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study. Hum Reprod 14(3):827\u2013832","journal-title":"Hum Reprod"},{"issue":"11","key":"10475_CR27","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1161\/01.CIR.0000120704.97934.41","volume":"109","author":"A Yndestad","year":"2004","unstructured":"Yndestad A, Ueland T, \u00d8ie E, Florholmen G, Halvorsen B, Attramadal H, Simonsen S, Fr\u00f8land SS, Gullestad L, Christensen G, Dam\u00e5s JK (2004) Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation 109(11):1379\u20131385","journal-title":"Circulation"},{"issue":"4","key":"10475_CR28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/cells11040742","volume":"11","author":"BA Bakrania","year":"2022","unstructured":"Bakrania BA, Palei AC, Bhattarai U, Chen Y, Granger JP, Shahul S (2022) Sustained elevated circulating activin A impairs global longitudinal strain in pregnant rats: a potential mechanism for preeclampsia-related cardiac dysfunction. Cells 11(4):742","journal-title":"Cells"},{"issue":"5","key":"10475_CR29","first-page":"380","volume":"4","author":"J Damp","year":"2016","unstructured":"Damp J, Givertz MM, Semigran M, Alharethi R, Ewald G, Felker GM, Bozkurt B, Boehmer J, Haythe J, Skopicki H, Hanley-Yanez K (2016) Relaxin-2 and soluble Flt1 levels in peripartum cardiomyopathy: results of the multicenter IPAC study. JACC: Heart Fail 4(5):380\u20138","journal-title":"JACC: Heart Fail"},{"issue":"7","key":"10475_CR30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/jpm12071021","volume":"12","author":"A Arag\u00f3n-Herrera","year":"2022","unstructured":"Arag\u00f3n-Herrera A, Feij\u00f3o-Band\u00edn S, Anido-Varela L, Mora\u00f1a-Fern\u00e1ndez S, Rosell\u00f3-Llet\u00ed E, Portol\u00e9s M, Taraz\u00f3n E, Gualillo O, Gonz\u00e1lez-Juanatey JR, Lago F (2022) Relaxin-2 as a potential biomarker in cardiovascular diseases. J Personalized Med 12(7):1021","journal-title":"J Personalized Med"},{"issue":"4","key":"10475_CR31","first-page":"585","volume":"69","author":"RJ Bell","year":"1987","unstructured":"Bell RJ, Eddie LW, Lester AR, Wood EC, Johnston PD, Niall HD (1987) Relaxin in human pregnancy serum measured with an homologous radioimmunoassay. Obstet Gynecol 69(4):585\u2013589","journal-title":"Obstet Gynecol"},{"issue":"9860","key":"10475_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","volume":"381","author":"JR Teerlink","year":"2013","unstructured":"Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF, Dorobantu MI (2013) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381(9860):29\u201339","journal-title":"Lancet"},{"issue":"1","key":"10475_CR33","doi-asserted-by":"publisher","first-page":"e86770","DOI":"10.1371\/journal.pone.0086770","volume":"9","author":"J Liu","year":"2014","unstructured":"Liu J, Wang Y, Chen M, Zhao W, Wang X, Wang H, Zhang Z, Zhang J, Xu L, Chen J, Yang X (2014) The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascular receptors. PLoS ONE 9(1):e86770","journal-title":"PLoS ONE"},{"key":"10475_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00395-015-0517-2","volume":"110","author":"A Haghikia","year":"2015","unstructured":"Haghikia A, Kaya Z, Schwab J, Westenfeld R, Ehlermann P, Bachelier K, Oettl R, von Kaisenberg CS, Katus HA, Bauersachs J, Hilfiker-Kleiner D (2015) Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathy. Basic Res Cardiol 110:1\u20139","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"10475_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.autrev.2008.12.003","volume":"8","author":"N Gleicher","year":"2009","unstructured":"Gleicher N, Elkayam U (2009) Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev 8(5):384\u2013387","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10475_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nm0595-433","volume":"1","author":"MA Beck","year":"1995","unstructured":"Beck MA, Shi Q, Morris VC, Levander OA (1995) Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat Med 1(5):433\u2013436","journal-title":"Nat Med"},{"issue":"15","key":"10475_CR37","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMc2401629","volume":"390","author":"N Gleicher","year":"2024","unstructured":"Gleicher N (2024) Peripartum cardiomyopathy. New England J Med 390(15):1443","journal-title":"New England J Med"},{"issue":"1","key":"10475_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.15420\/cfr.2018:2:2","volume":"4","author":"T Koenig","year":"2018","unstructured":"Koenig T, Bauersachs J, Hilfiker-Kleiner D (2018) Bromocriptine for the treatment of peripartum cardiomyopathy. Card Fail Rev 4(1):46","journal-title":"Card Fail Rev"},{"issue":"2","key":"10475_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra2306667","volume":"390","author":"Z Arany","year":"2024","unstructured":"Arany Z (2024) Peripartum cardiomyopathy. N Engl J Med 390(2):154\u2013164","journal-title":"N Engl J Med"},{"issue":"17","key":"10475_CR40","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):e263-421","journal-title":"J Am Coll Cardiol"},{"issue":"34","key":"10475_CR41","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","volume":"39","author":"V Regitz-Zagrosek","year":"2018","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstr\u00f6m-Lundqvist C, Cifkova R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM (2018) 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J 39(34):3165\u20133241","journal-title":"Eur Heart J"},{"issue":"19","key":"10475_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13006-024-00673-6","volume":"29","author":"A Noll","year":"2024","unstructured":"Noll A, Kawamoto KR, Dassanayake MT, Leuenberger L, Spehar SM, Wu J, Langen E, Davis MB (2024) Breastfeeding in patients with peripartum cardiomyopathy: clinical outcomes and physician counseling. Int Breastfeed J 29(19):73","journal-title":"Int Breastfeed J"},{"key":"10475_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-020-01739-z","volume":"20","author":"KM Karaye","year":"2020","unstructured":"Karaye KM, Sa\u2019idu H, Balarabe SA, Ishaq NA, Sanni B, Abubakar H, Mohammed BL, Abdulsalam T, Tukur J, Mohammed IY (2020) Selenium supplementation in patients with peripartum cardiomyopathy: a proof-of-concept trial. BMC Cardiovasc Disord 20:1","journal-title":"BMC Cardiovasc Disord"},{"issue":"35","key":"10475_CR44","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","volume":"38","author":"D Hilfiker-Kleiner","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Berliner D, Vogel-Claussen J, Schwab J, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R (2017) Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J 38(35):2671\u20132679","journal-title":"Eur Heart J"},{"issue":"5","key":"10475_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/clc.22932","volume":"41","author":"ZU Asad","year":"2018","unstructured":"Asad ZU, Maiwand M, Farah F, Dasari TW (2018) Peripartum cardiomyopathy: a systematic review of the literature. Clin Cardiol 41(5):693\u2013697","journal-title":"Clin Cardiol"},{"issue":"1","key":"10475_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jacc.2023.04.043","volume":"82","author":"P Pachariyanon","year":"2023","unstructured":"Pachariyanon P, Bogabathina H, Jaisingh K, Modi M, Modi K (2023) Long-term outcomes of women with peripartum cardiomyopathy having subsequent pregnancies. J Am Coll Cardiol 82(1):16\u201326","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10475_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1874192401913010013","volume":"13","author":"MK Mahowald","year":"2019","unstructured":"Mahowald MK, Basu N, Subramaniam L, Scott R, Davis MB (2019) Long-term outcomes in peripartum cardiomyopathy. Open Cardiovasc Med J 13(1):13\u201323","journal-title":"Open Cardiovasc Med J"},{"issue":"1","key":"10475_CR48","doi-asserted-by":"publisher","first-page":"e002626","DOI":"10.1136\/openhrt-2024-002626","volume":"11","author":"MA Wijayanto","year":"2024","unstructured":"Wijayanto MA, Myrtha R, Lukas GA, Rahma AA, Hanifa SN, Zahira HA, Ilyas MF (2024) Outcomes of subsequent pregnancy in women with peripartum cardiomyopathy: a systematic review and meta-analysis. Open Heart 11(1):e002626","journal-title":"Open Heart"},{"issue":"12","key":"10475_CR49","doi-asserted-by":"publisher","first-page":"550","DOI":"10.14740\/jmc2698w","volume":"7","author":"N Takeuchi","year":"2016","unstructured":"Takeuchi N, Emori K, Soneda J, Mohri K, Takada M (2016) A case of peripartum cardiomyopathy affected by left ventricle thrombus. J Med Cases 7(12):550\u2013553","journal-title":"J Med Cases"},{"issue":"9","key":"10475_CR50","doi-asserted-by":"publisher","first-page":"100313","DOI":"10.1016\/j.ajpc.2021.100313","volume":"1","author":"K Luthra","year":"2022","unstructured":"Luthra K, Avula SR, Raju M, Gangu K, Waqar Z, Doddamani R, Settipalle BH, Shah J, Ali SS, Singh H (2022) Risk factors and outcomes associated with left ventricular thrombus in patients with peripartum cardiomyopathy: an insight from National Inpatient Sample Database. Am J Prev Cardiol 1(9):100313","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"10475_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ehf2.14158","volume":"10","author":"K Fu","year":"2023","unstructured":"Fu K, Zhang H, Chen N, Hu Y, Xiao J, Zhang X, Lin Z, Lu H, Ji X (2023) Risk factors for intracardiac thrombus in peripartum cardiomyopathy: a retrospective study in China. ESC Heart Fail 10(1):148\u2013158","journal-title":"ESC Heart Fail"},{"issue":"37","key":"10475_CR52","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, De Winter T (2023) 2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J 44(37):3503\u20133626","journal-title":"Eur Heart J"},{"issue":"23","key":"10475_CR53","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS, Lenihan D, Lewis EF, McNamara DM, Pahl E (2016) Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation 134(23):e579-646","journal-title":"Circulation"},{"issue":"15","key":"10475_CR54","first-page":"1649","volume":"3","author":"E Yucel","year":"2021","unstructured":"Yucel E, Davis EF, Scott N, Lewis GD, DeFaria YD (2021) Exercise ventricular reserve among women with a history of peripartum cardiomyopathy. Case Reports 3(15):1649\u20131653","journal-title":"Case Reports"},{"issue":"1","key":"10475_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/biom14010103","volume":"14","author":"KE Kryczka","year":"2024","unstructured":"Kryczka KE, Demkow M, Dzieli\u0144ska Z (2024) Biomarkers in peripartum cardiomyopathy\u2014what we know and what is still to be found. Biomolecules 14(1):103","journal-title":"Biomolecules"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10475-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-024-10475-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-024-10475-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T08:17:22Z","timestamp":1738829842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-024-10475-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["10475"],"URL":"https:\/\/doi.org\/10.1007\/s10741-024-10475-x","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"7 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}